Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» clinical trials
clinical trials
Vertex Presents Positive, Updated VX-880 Results From Ongoing Phase 1/2 Study in Type 1 Diabetes at the European Association for the Study of Diabetes 59th Annual Meeting
Vertex Presents Positive, Updated VX-880 Results From Ongoing Phase 1/2 Study in Type 1 Diabetes at the European Association for the Study of Diabetes 59th Annual Meeting
Businesswire
Vertex Pharmaceuticals
VX-880
clinical trials
type 1 diabetes
Flag link:
Takeda to Withdraw Oncology Drug Exkivity from U.S. Market
Takeda to Withdraw Oncology Drug Exkivity from U.S. Market
Managed Healthcare Executive
Takeda
Exkivity
clinical trials
non-small cell lung cancer
Flag link:
BPGbio to accelerate pancreatic cancer drug after ‘promising’ initial trials
BPGbio to accelerate pancreatic cancer drug after ‘promising’ initial trials
Biopharma Reporter
BPGbio
artificial intelligence
pancreatic cancer
BPM 31510
clinical trials
Flag link:
Henlius and OncoHost partner to predict trial outcomes using machine learning
Henlius and OncoHost partner to predict trial outcomes using machine learning
Clinical Trials Arena
Henlius
OncoHost
PROphet
clinical trials
machine learning
artificial intelligence
Flag link:
Syndax stops pivotal cancer trial early for efficacy but details disappoint, sending stock down
Syndax stops pivotal cancer trial early for efficacy but details disappoint, sending stock down
Fierce Biotech
Syndax Pharmaceuticals
clinical trials
revumenib
AML
Flag link:
Novartis eyes accelerated FDA approval for iptacopan across multiple indications
Novartis eyes accelerated FDA approval for iptacopan across multiple indications
Clinical Trials Arena
Novartis
clinical trials
iptacopan
IgA nephropathy
kidney disease
Flag link:
AbbVie’s venetoclax fails Phase III myeloma trial
AbbVie’s venetoclax fails Phase III myeloma trial
Clinical Trials Arena
AbbVie
venetoclax
Multiple Myeloma
clinical trials
Flag link:
FDA Launches Pilot Program to Help Further Accelerate Development of Rare Disease Therapies
FDA Launches Pilot Program to Help Further Accelerate Development of Rare Disease Therapies
Applied Clinical Trials Online
FDA
Rare Diseases
clinical trials
drug development
Flag link:
Regeneron’s linvoseltamab shows early and durable response in pre-treated MM
Regeneron’s linvoseltamab shows early and durable response in pre-treated MM
Clinical Trials Arena
Regeneron
clinical trials
bispecific antibodies
linvoseltamab
Flag link:
Structure Therapeutics surges on promising early stage obesity drug data
Structure Therapeutics surges on promising early stage obesity drug data
Reuters
Structure Therapeutics
obesity
weight loss
clinical trials
GSBR-1290
Flag link:
Bionomics’ PTSD Candidate Clears Phase IIb Study, Stock Jumps 415%
Bionomics’ PTSD Candidate Clears Phase IIb Study, Stock Jumps 415%
BioSpace
Bionomics
PTSD
BNC210
clinical trials
Flag link:
Aleta aims for pivotal US trial with CAR T-cell engager
Aleta aims for pivotal US trial with CAR T-cell engager
Clinical Trials Arena
Aleta Biotherapeutics
CAR-T
ALETA-001
clinical trials
Flag link:
Patient Death Likely from Virus Used to Deliver Gene-Editing Therapy: NEJM Study
Patient Death Likely from Virus Used to Deliver Gene-Editing Therapy: NEJM Study
BioSpace
NEJM
clinical trials
Duchenne Muscular Dystrophy
patient deaths
Astellas
Pfizer
Flag link:
Gilead Axes Phase III Magrolimab Trial Based on Disappointing Data
Gilead Axes Phase III Magrolimab Trial Based on Disappointing Data
BioSpace
Gilead Sciences
magrolimab
clinical trials
blood cancers
Flag link:
Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy
Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy
BioSpace
Cardiff Oncology
pancreatic cancer
Onvansertib
clinical trials
Flag link:
Immunovant shares surge as early antibody treatment data beats expectations
Immunovant shares surge as early antibody treatment data beats expectations
Yahoo/Reuters
Roivant
Immunovant
antibodies
clinical trials
IMVT-1402
autoimmune diseases
Flag link:
Ionis' lipid-lowering drug hits phase 3 goal, raising hopes in untapped rare disease market
Ionis' lipid-lowering drug hits phase 3 goal, raising hopes in untapped rare disease market
Fierce Biotech
Ionis Pharmaceuticals
clinical trials
olezarsen
familial chylomicronemia syndrome
Flag link:
Elderly exclusion: Clinical trials still fall short enrolling older adults
Elderly exclusion: Clinical trials still fall short enrolling older adults
Pharma Voice
elderly
clinical trials
Flag link:
Daiichi Sankyo reports positive results from trial of breast cancer therapy
Daiichi Sankyo reports positive results from trial of breast cancer therapy
Clinical Trials Arena
Daiichi Sankyo
clinical trials
Dato-DXd
breast cancer
Flag link:
Novartis eyes first-line use of Lutathera after trial win
Novartis eyes first-line use of Lutathera after trial win
Pharmaphorum
Novartis
radioligands
clinical trials
neuroendocrine tumors
Lutathera
Flag link:
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »